COMMUNIQUÉS West-GlobeNewswire

Golden Leaf Holdings to Hold Conference Call to Review Second Quarter 2018 Results
20/08/2018
PORTLAND, Ore., Aug. 20, 2018 (GLOBE NEWSWIRE) -- Golden Leaf Holdings Ltd. ("GLH" or the "Company") (CSE:GLH) (OTCQB:GLDFF), a cannabis company with cultivation, production and retail operations built around recognized [...]
Novo Nordisk A/S - Share repurchase programme
20/08/2018
Bagsværd, Denmark, 20 August 2018 - On 10 August 2018, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 [...]
Acer Therapeutics to Present at the 20th Annual H.C. Wainwright Conference
20/08/2018
NEWTON, Mass., Aug. 20, 2018 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (Nasdaq: ACER), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious rare and ultra-rare [...]
Newly Published Data Show Daxor Corporation's BVA-100 Is Superior To Formula-Based Estimates of Blood Volume In Assessing Patients With Heart Failure
20/08/2018
NEW YORK, Aug. 20, 2018 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR) , an innovative medical instrumentation and biotechnology company focused on blood volume measurement today announces the publication of an [...]
Sarepta Therapeutics Announces Recipients of Route 79, The Duchenne Scholarship Program
20/08/2018
-- 10 academic scholarships awarded to students diagnosed with Duchenne muscular dystrophy as they pursue their post-secondary education this fall -- CAMBRIDGE, Mass., Aug. 20, 2018 (GLOBE NEWSWIRE) -- Sarepta [...]
Fractionated Dosing Improves Tolerability and Safety of Cellectar’s CLR 131 in R/R Multiple Myeloma Patients
20/08/2018
Positive Results from Cohort 5 of Phase 1b Trial Company Intends to Initiate a Sixth Cohort and Transition Ongoing Phase 2 Trial to a Fractionated Dose MADISON, Wis., Aug. 20, 2018 (GLOBE NEWSWIRE) -- Cellectar [...]
Taiwan Liposome Company Reports Positive Top-Line Data from Phase II Clinical Trial of TLC599 in Knee Osteoarthritis Pain
20/08/2018
Primary endpoint and key secondary endpoints met TLC599 demonstrated statistically significant improvement over placebo through Weeks 12, 16, 20, and 24 TLC599 was well-tolerated with no treatment-related serious [...]
Catalyst Pharmaceuticals Appoints Dr. Stanley Iyadurai as Vice President of Clinical Development
20/08/2018
CORAL GABLES, Fla., Aug. 20, 2018 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq: CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies for people with [...]
HTG Molecular Announces 2nd Amendment to Second Statement of Work with QIAGEN Manchester Limited
20/08/2018
TUCSON, Ariz., Aug. 20, 2018 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a provider of instruments, reagents, and services for molecular profiling applications, today announced that it has [...]
Vericel Announces Appointment of Jonathan Hopper as Chief Medical Officer
20/08/2018
CAMBRIDGE, Mass., Aug. 20, 2018 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced cell therapies for the sports medicine and severe burn care markets, today announced the appointment of [...]
Intra-Cellular Therapies Appoints Dr. Suresh Durgam as Senior Vice President, Late Stage Clinical Development and Medical Affairs
20/08/2018
NEW YORK, Aug. 20, 2018 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq:ITCI), a biopharmaceutical company focused on the development of therapeutics for central nervous system (CNS) disorders, announced the [...]
Humanigen Announces Positive Topline Study Results
20/08/2018
Study Demonstrates that GM-CSF Blockade in Combination with Chimeric Antigen Receptor T Cell Therapy (CAR-T) Prevents the Onset and Severity of Neurotoxicity and Cytokine Release Syndrome BURLINGAME, Calif., Aug. 20, [...]
BrainsWay Receives First Ever FDA Clearance of a Non-Invasive Device for Treatment of Obsessive-Compulsive Disorder
20/08/2018
BrainsWay’s deep transcranial magnetic stimulation (Deep TMS) system is a best-in-class device designed to maximize electromagnetic stimulation of deep and broad brain regions, helping to launch a new era in brain [...]
Athenex Appoints Randoll Sze as Chief Financial Officer
20/08/2018
BUFFALO, N.Y., Aug. 20, 2018 (GLOBE NEWSWIRE) -- Athenex, Inc. (Nasdaq: ATNX), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of [...]
BioSig Appoints Johnson & Johnson Veteran Amy Scott
20/08/2018
Former Biosense Webster Director of Strategic Partnerships to drive commercial adoption of PURE EP Santa Monica, CA, Aug. 20, 2018 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company [...]
Coherus BioSciences Management to Participate in Two Investor Healthcare Conferences in September
20/08/2018
REDWOOD CITY, Calif., Aug. 20, 2018 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Nasdaq: CHRS), today announced that senior management will participate in two upcoming investor healthcare conferences in September. [...]
Delcath Announces Beginning of Enrollment of Amended Metastatic Ocular Melanoma Registration Trial
20/08/2018
Stanford University Medical Center First Location to Begin Enrollment Under Single Arm Protocol NEW YORK, Aug. 20, 2018 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (OTCQB: DCTH), an interventional oncology company focused [...]
Transactions under Novozymes’ stock buyback program
20/08/2018
Please read the full announcement in the attached PDF Attachment 2018_50_Stock_Buybackprogram_EN
European Medicines Agency Authorizes Deferral of Paediatric Investigation Plan for Trogarzo™
20/08/2018
MONTREAL, Aug. 20, 2018 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX:TH) today announced that the Paediatric Committee of the European Medicines Agency (“EMA”) has accepted to defer the initiation [...]

Pages